Suchergebnisse - "Stagno, Fabio"

PubPharm (15)

1

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib : 10-year followup of the GIMEMA CML 0307 study

enthalten in: Haematologica | 2022

von Gugliotta, G. | Castagnetti, F. | Breccia, M. | +23

2

Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib

enthalten in: Annals of hematology | 2021

von Caocci, G. | Mulas, O. | Capodanno, I. | +33

CommentIn: Ann Hematol. 2021 May;100(5):1335-1336. - PMID 33474630

3

Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study

enthalten in: Leukemia | 2021

von Breccia, M. | Pregno, P. | Castagnetti, F. | +13

4

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs : First interim analysis of OPTkIMA study

enthalten in: Cancer medicine | 2021

von Malagola, M. | Iurlo, A. | Abruzzese, E. | +29

ErratumIn: Cancer Med. 2021 May 2;:. - PMID 33934555

5

Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy : A Case Report

enthalten in: In vivo (Athens, Greece) | 2020

von Manzella, L. | Tirrò, E. | Vitale, S. | +9

6

Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors

enthalten in: International journal of cardiology | 2020

von Caocci, G. | Mulas, O. | Annunziata, M. | +31

7

Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22)

enthalten in: Anticancer research | 2019

von Tirrò, E. | Massimino, M. | Stella, S. | +12

8

Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib

enthalten in: Cancer | 2018

von Efficace, F. | Castagnetti, F. | Martino, B. | +22

9

Nilotinib 300 mg twice daily : an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients

enthalten in: Haematologica | 2016

von Castagnetti, F. | Breccia, M. | Gugliotta, G. | +23

10

Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia

enthalten in: American journal of hematology | 2016

von Gugliotta, G. | Castagnetti, F. | Breccia, M. | +27